1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Strong Performer, Getting Expensive
In 3 Starfolio Baskets
Download real time
2242.10 2.60 (0.12%)
25.08% Gain from 52W Low
280.5K
NSE+BSE Volume

NSE 21 Jul, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Glenmark gets USFDA nod for the expanded use of Ryaltris nasal spray for children aged 6-12 years See details